ALNY News 53.86 Alnylam Pharmaceuticals (ALNY)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Alnylam Pharmaceuticals (ALNY) 53.86 $ALNY

Down 17%: Is Isis Pharmaceuticals Worth Buying Now?
Todd Campbell, The Motley Fool - Motley Fool - Tue Apr 15, 4:31PM CDT
In just a few months Isis Pharmaceuticals has gone from investment darling to investment dog, dropping nearly 20% since the beginning of this year. But little has changed at Isis, suggesting the recent move lower is tied more to profit-taking...

Watch for Alnylam Pharmaceuticals to Potentially Rebound After Falling 2.78% Yesterday
Comtex SmarTrend(R) - Mon Apr 14, 5:18PM CDT
Alnylam Pharmaceuticals (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $52.02 to a high of $57.56. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $54.92 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Why Alnylam Pharmaceuticals (ALNY) Stock is Down Today
at The Street - Mon Apr 14, 2:15PM CDT
Alnylam Pharmaceuticals (ALNY) dipped Monday amid reports that Novartis (NVS) is closing a significant portion of its RNAi research endeavors in Boston. FierceBiotech reported the pharmaceutical giant's confirmation that ongoing problems in...

Alnylam Pharmaceuticals Down 21.6% Since SmarTrend Downtrend Call (ALNY)
Comtex SmarTrend(R) - Fri Apr 11, 10:06AM CDT
SmarTrend identified a Downtrend for Alnylam Pharmaceuticals (NASDAQ:ALNY) on March 7th, 2014 at $73.88. In approximately 1 month, Alnylam Pharmaceuticals has returned 21.58% as of today's recent price of $57.94.

Alnylam Pharmaceuticals (ALNY) Showing Signs Of A Dead Cat Bounce Today
at The Street - Fri Apr 11, 9:08AM CDT
Trade-Ideas LLC identified Alnylam Pharmaceuticals (ALNY) as a "dead cat bounce" (down big yesterday but up big today) candidate

Nasdaq stocks posting largest percentage decreases
AP - Thu Apr 10, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:

Healthcare Companies Report Results, Patents, and Stock Movements - Analyst Notes on Puma Biotechnology, Alnylam, INSYS Therapeutics, Peregrine Pharmaceuticals, and VIVUS
PR Newswire - Thu Apr 10, 11:28AM CDT
Today, Analysts Review released its analysts' notes regarding Puma Biotechnology, Inc. (NYSE: PBYI), Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), INSYS Therapeutics, Inc. (NASDAQ: INSY), Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM), and VIVUS Inc (NYSE: ESC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Notable Two Hundred Day Moving Average Cross - ALNY
MarketNewsVideo.com - Thu Apr 10, 10:58AM CDT
In trading on Thursday, shares of Alnylam Pharmaceuticals Inc crossed below their 200 day moving average of $61.49, changing hands as low as $59.71 per share. Alnylam Pharmaceuticals Inc shares are currently trading down about 7.5% on the day.

Look for Shares of Alnylam Pharmaceuticals to Potentially Pullback after Yesterday's 5.49% Rise
Comtex SmarTrend(R) - Wed Apr 09, 4:42PM CDT
Alnylam Pharmaceuticals (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $62.78 to a high of $66.50. Yesterday, the shares gained 5.5%, which took the trading range above the 3-day high of $65.13 on volume of 986,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

EPO Upholds Alnylam's McSwiggen Patent - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 6:00PM CDT
The EPO has upheld Alnylam's McSwiggen patent in oral opposition proceedings in Germany.

Alnylam's McSwiggen Patent Upheld in European Opposition Proceedings
Business Wire - Mon Apr 07, 7:02AM CDT
Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has upheld the McSwiggen EP 1423406 ('406) patent in oral opposition proceedings in Munich, Germany. The McSwiggen patent estate broadly describes chemical modifications of RNAi therapeutics that the company believes are critical for achieving "drug-like" properties in siRNA, the molecules that mediate RNAi. The patent is owned by Alnylam, and was recently obtained through the company's acquisition of Sirna Therapeutics from Merck. The McSwiggen patent family comprises a core component of Alnylam's overall intellectual property (IP) estate for the advancement of RNAi therapeutics as a new class of medicines.

15.5% Return Seen to Date on SmarTrend Alnylam Pharmaceuticals Call (ALNY)
Comtex SmarTrend(R) - Fri Apr 04, 9:27AM CDT
SmarTrend identified a Downtrend for Alnylam Pharmaceuticals (NASDAQ:ALNY) on March 7th, 2014 at $73.88. In approximately 4 weeks, Alnylam Pharmaceuticals has returned 15.48% as of today's recent price of $62.45.

Alnylam to Webcast Presentation at 13th Annual Needham Healthcare Conference
Business Wire - Wed Apr 02, 3:00PM CDT
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 13th Annual Needham Healthcare Conference on Wednesday, April 9, 2014 at 12:50 p.m. ET at the Westin Grand Central Hotel in New York City.

Today’s Top Biotech Stories: MannKind, GSK, Myriad, and Alnylam
Leo Sun, The Motley Fool - Motley Fool - Wed Apr 02, 8:22AM CDT
Let's take a look a four stocks -- MannKind , GlaxoSmithKline , Myriad Genetics , and Alnylam Pharmaceuticals -- all of which could loom large in health care headlines this Wednesday morning. FDA advisory panel recommends the approval of...

Alnylam Receives Positive Opinion for Orphan Drug Designation in the European Union for ALN-TTRsc, a Subcutaneously Delivered RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis (ATTR)
Business Wire - Wed Apr 02, 7:02AM CDT
Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion recommending ALN-TTRsc for designation as an orphan medicinal product for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR).

Why American Capital Ltd., Alnylam Pharmaceuticals Inc., and Micron Technology Inc. are Today's 3 Be
Dan Carroll, The Motley Fool - Motley Fool - Mon Mar 31, 4:15PM CDT
Reassuring comments from Federal Reserve Chairwoman Janet Yellen helped the S&P 500 race to a 0.8% gain on the last day of March. The index closed at just over 1,872, capping off a so-so month for the markets. Still, it's been a great run for...

Today's Dead Cat Bounce Stock: Alnylam Pharmaceuticals (ALNY)
at The Street - Mon Mar 31, 8:55AM CDT
Trade-Ideas LLC identified Alnylam Pharmaceuticals (ALNY) as a "dead cat bounce" (down big yesterday but up big today) candidate

Watch for Alnylam Pharmaceuticals to Potentially Rebound After Falling 5.20% Yesterday
Comtex SmarTrend(R) - Fri Mar 28, 4:56PM CDT
Alnylam Pharmaceuticals (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $60.28 to a high of $66.45. Yesterday, the shares fell 5.2%, which took the trading range below the 3-day low of $61.11 on volume of 1.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

This Rapidly Evolving New Cholesterol Treatment Pathway Demands Your Attention
Sean Williams, The Motley Fool - Motley Fool - Fri Mar 28, 11:08AM CDT
According to the National Institutes of Health, there are 163,000 clinical studies currently under way throughout 185 countries. This is why it can sometimes be difficult to get the attention of investors when a revolutionary new treatment pathway...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Inventor Launches Handy Solution for Kids' Car Sickness

Updated Category News Views 29

A Fresh Take on an Age-Old Problem Just when you thought the universe had thrown all it could at beleaguered parents, here comes a nifty little accessory tackling those dreaded uphill battles with kids and car rides. Some bright spark from Middleburgh, New York, sick of scrubbing car seats and clothing every other road trip, came up with a clever little invention named...

Continue Reading
Go NYC's Perks: Making Commutes Rewarding in NYC

Updated Category News Views 88

Go NYC's Perks: Turning Commutes into Gains I’ve seen a lot of schemes aimed at getting folks to change their travel habits, but this one from Go NYC caught my attention. These guys are trying to squeeze some extra value out of the daily grind for anyone hoofing it across the Big Apple. A new rewards program named Perks kicks off, offering all kinds of discounts and...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 185

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Priceline's Cyber Week: A Pocket-Friendly Travel Bonanza

Updated Category News Views 183

Unpacking Priceline's Cyber Week Bonanza Alright, folks, grab your booking hats because Priceline is back with its annual Cyber Week extravaganza, aiming to give travelers a shot in the arm of savings just when inflation has everyone pinching pennies. From November 16 through December 2, Priceline rolls out the red carpet for vacation planners, offering eye-popping...

Continue Reading
Webull Faces FINRA Fine and Legal Battle Ahead

Updated Category News Views 187

Webull's Compliance Headache Webull’s been knocked around again. This time, the Financial Industry Regulatory Authority (FINRA) slapped it with a hefty $4.2 million fine. Talk about a hit to the wallet! It all boils down to them failing to roll out some basic anti-money laundering (AML) and other crucial compliance programs. This is no small oversight, and it's got...

Continue Reading
Medtronic's Bold Move to Own Carotid Market Full-Scale

Updated Category News Views 163

When a giant like Medtronic makes a move, you can bet investors take notice, and this latest acquisition is no exception. They’re reaching into their deep pockets to acquire Contego Medical, a company shaking up the world of carotid artery disease treatments. It’s a tactical strike to solidify their leadership in cardiovascular solutions. Medtronic's Bet on Innovation...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 91

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
Veterans Find a Haven in Home Helpers® Franchise

Updated Category News Views 108

Veterans Thriving at Home Helpers® Tossing out a warm welcome to fresh horizons post-military, Home Helpers® Home Care is serving up more than just compassionate care—it’s become a bonafide haven for veterans diving into the world of franchising. This isn’t just an indie pat on the back; according to the latest scoop from Franchise Business Review, Home Helpers®...

Continue Reading
Xiong'an New Area: People's Priorities Reshape Living Spaces

Updated Category News Views 78

Building a City for the People This here is about prioritizing people over skylines. Xiong'an New Area in Hebei Province is shaping up to be more than just a place on the map; it's an experiment in redefining urban living. Skyscrapers and traffic jams? Not on this menu. Instead, nature paves a graceful dance floor between mid-rise residences. Forget your bustling city...

Continue Reading
Better Life Science: Revolutionizing At-Home STI Testing

Updated Category News Views 164

Paving a New Path for STI Testing Accessibility The landscape of STI testing is undergoing a significant shift, and Better Life Science is at the helm with their innovative STD Hero at-home testing service. With a splash in the latest AVN report, they're turning heads in both the clinical world and in mainstream society. This ain't just about checking boxes in health...

Continue Reading

Top 5 Most Recently Viewed Articles

H&E Equipment Services Reveals Q3 2024 Performance Insights

Updated Category News Views 338

H&E Equipment Services Reports Q3 2024 Financial Results H&E Equipment Services, Inc. (NASDAQ: HEES), commonly known as H&E Rentals, recently issued its financial results for the third quarter of 2024. The Company has made significant strides in expanding its branch network, adding eight new locations during the quarter, which brings its total to 157 branches across...

Continue Reading
Automotive V2X Market Trends: A Roadmap to 2031

Updated Category News Views 148

Automotive V2X Market Growth Insights The automotive V2X (Vehicle-to-Everything) market is set for a remarkable transformation, anticipated to expand with a compound annual growth rate of 25.1% from 2024 to 2031. The market is projected to reach a size of US$2.3 billion by 2031. Insights from recent research indicate a shift in dynamics within this evolving market,...

Continue Reading
Toll Brothers Celebrates New Luxury Amenities in Forestville Village

Updated Category News Views 250

Toll Brothers Introduces Exceptional Amenities Toll Brothers, Inc. (NYSE:TOL), a well-respected name in luxury homebuilding, recently celebrated the opening of a fantastic amenity center at Forestville Village. This vibrant community in Knightdale features beautifully designed single-family homes and townhomes, now enhanced with access to resort-style amenities. A...

Continue Reading
Acadia Pharmaceuticals Celebrates Strong Q3 2024 Financial Growth

Updated Category News Views 58

Acadia Pharmaceuticals Reports Financial Results for Q3 2024 Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) has shared encouraging financial results for the third quarter of 2024. The company has showcased a remarkable performance that reflects its strong commercial presence and growth within the pharmaceutical industry. This report provides insights into the company's...

Continue Reading
Crowley Enhances Logistics for Wreaths Across America Initiative

Updated Category News Views 208

Crowley Enhances Logistics for Wreaths Across America Initiative Crowley is taking significant steps to expand its logistical support for the Wreaths Across America program, reflecting its strong commitment to honoring U.S. military personnel. The company is facilitating this through financial sponsorship along with in-kind transportation and logistics services. Expanded...

Continue Reading